Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 5—May 2004
Dispatch

Mycobacterium africanum Cases, California

Edward Desmond*Comments to Author , Ameena T. Ahmed*, William S. Probert*, Janet Ely*, Yvonne Jang*, Cynthia A. Sanders*, Shou-Yean Lin*, and Jennifer Flood*
Author affiliations: *California Department of Health Services, Berkeley, California

Main Article

Table 2

Phenotypic and molecular characteristics of Mycobacterium africanum isolates and country of birth for five patients

Patient No. of copies of IS6110 (bands) Spoligo-typing pattern missing spacers 8,9,39? OxyR285a Codon katG463 sequenceb Presence of RD9 deletion? PZA susceptibilityc Niacin pro-duction Nitratereduc-tiond Major site of disease Birth country
A
10
Yes
G
CTG
Yes
S
+
3+
Lung
South Africa
B
3
Yes
G
CTG
Yes
S
N.D.e
N.D.
Lung
Ivory Coast
C
9f
Yes
G
CTG
Yes
S
N.D.
N.D.
Lung
South Africa
D
11
Yes
G
CTG
Yes
S
+
4+
Lung
Vietnam
E 9 Yes G CTG Yes S + 3+ Pancreas USA

aIsolates of M. bovis do not have G at this site.
bCTG is found in M. bovis and M. africanum, but not in most strains of M. tuberculosis.
cS, susceptible; PZA, pyrazinamide.
d3+ and 4+ reactions are considered positive.
eND, not done (because the culture lost viability).
fRestriction fragment length polymorphism patterns for isolates from patients C and E were identical.

Main Article

Page created: June 14, 2011
Page updated: June 14, 2011
Page reviewed: June 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external